Sun Pharma Advanced Research Company Ltd Q4 FY2023-2024 Results: Summary
Revenue | ₹20.96Cr |
Net Profits | ₹-105.79Cr |
Net Profit Margins | -504.72% |
Highlights
Sun Pharma Advanced Research Company Ltd’s revenue fell -64.12% since last year same period to ₹20.96Cr in the Q4 2023-2024. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 3.51% jump in its revenue since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit fell -29.03% since last year same period to ₹-105.79Cr in the Q4 2023-2024. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -6.16% fall in its net profits since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit margin fell -259.63% since last year same period to -504.72% in the Q4 2023-2024. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -2.57% fall in its net profit margins since last 3-months.
